AC
EDIT icon

AXQ Capital’s Editas Medicine EDIT Stock Holding History

AXQ Capital’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
+36,452
New +$107K 0.01% 807
2025
Q3 		– Sell
-47,083
Closed -$104K – 647
2025
Q2 		$104K Buy
+47,083
New +$77K 0.03% 516
2023
Q3 		– Sell
-10,072
Closed -$82.9K – 508
2023
Q2 		$82.9K Buy
+10,072
New +$87.7K 0.1% 249
2023
Q1 		– Sell
-20,801
Closed -$185K – 516
2022
Q4 		$185K Buy
+20,801
New +$228K 0.13% 275

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

AXQ Capital's EDIT Position: Q2 2026 in Review

AXQ Capital opened a new position in Editas Medicine (EDIT) in Q2 2026: 36,452 shares worth $118K. The stake represents 0.01% of the portfolio and ranks #807 among its holdings. This is a return to the name: AXQ Capital previously reported a position in EDIT as recently as Q2 2025.

AXQ Capital first reported a position in EDIT in Q4 2022 and has held it in 4 quarters since. The position peaked at $185K in Q4 2022. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • AXQ Capital held 36,452 shares of Editas Medicine worth $118K as of Q2 2026.
  • Editas Medicine was a new AXQ Capital position in Q2 2026.
  • Editas Medicine made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #807 holding.
  • AXQ Capital first reported a position in Editas Medicine in Q4 2022 and has held it in 4 quarters since.
  • AXQ Capital's Editas Medicine position peaked at $185K in Q4 2022.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.